Harrys A. Torres

6.1k total citations
114 papers, 3.6k citations indexed

About

Harrys A. Torres is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Harrys A. Torres has authored 114 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Epidemiology, 63 papers in Hepatology and 35 papers in Infectious Diseases. Recurrent topics in Harrys A. Torres's work include Hepatitis C virus research (61 papers), Hepatitis B Virus Studies (29 papers) and Liver Disease Diagnosis and Treatment (27 papers). Harrys A. Torres is often cited by papers focused on Hepatitis C virus research (61 papers), Hepatitis B Virus Studies (29 papers) and Liver Disease Diagnosis and Treatment (27 papers). Harrys A. Torres collaborates with scholars based in United States, Egypt and France. Harrys A. Torres's co-authors include Dimitrios P. Kontoyiannis, Issam Raad, Ray Hachem, Parag Mahale, Roy F. Chemaly, Gerald P. Bodey, Russell E. Lewis, Marta Davila, Ying Jiang and Gustavo Rivero and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Harrys A. Torres

108 papers receiving 3.5k citations

Peers

Harrys A. Torres
Sook‐Hyang Jeong South Korea
Frank P. Kroon Netherlands
Edward Tabor United States
Maha Boktour United States
Harrys A. Torres
Citations per year, relative to Harrys A. Torres Harrys A. Torres (= 1×) peers Pierre–Yves Bochud

Countries citing papers authored by Harrys A. Torres

Since Specialization
Citations

This map shows the geographic impact of Harrys A. Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harrys A. Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harrys A. Torres more than expected).

Fields of papers citing papers by Harrys A. Torres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harrys A. Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harrys A. Torres. The network helps show where Harrys A. Torres may publish in the future.

Co-authorship network of co-authors of Harrys A. Torres

This figure shows the co-authorship network connecting the top 25 collaborators of Harrys A. Torres. A scholar is included among the top collaborators of Harrys A. Torres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harrys A. Torres. Harrys A. Torres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
George, Mónica, Sairah Ahmed, Sheeba K. Thomas, et al.. (2025). Direct‐Acting Antivirals Induce Lymphoproliferative Disease Response in HCV‐Infected Patients With Indolent B‐Cell Non‐Hodgkin’s Lymphoma: A Prospective Observational Study. Hematological Oncology. 43(2). e70044–e70044. 1 indexed citations
2.
Mallet, Vincent, et al.. (2024). Management of Hepatitis B Virus and Hepatitis C Virus Infections in Patients with Cancer Receiving Immune Checkpoint Inhibitors. SHILAP Revista de lepidopterología. 7(2). 111–121. 3 indexed citations
3.
Torres, Harrys A., et al.. (2024). Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center. Journal of the National Comprehensive Cancer Network. 22(2D). 1 indexed citations
4.
Ahmed, Sairah, Sheeba K. Thomas, Luis Fayad, et al.. (2023). Hepatitis B Virus Reactivation in Patients Receiving Bruton Tyrosine Kinase Inhibitors. Clinical Lymphoma Myeloma & Leukemia. 23(8). 610–615. 7 indexed citations
5.
Chiu, Chiayu Q., et al.. (2023). False-Reactive Fourth-Generation Human Immunodeficiency Virus Testing in Cancer Patients. Clinical Infectious Diseases. 78(3). 674–680. 1 indexed citations
6.
Torres, Harrys A., et al.. (2022). Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies. Clinical Microbiology and Infection. 28(10). 1321–1327. 33 indexed citations
7.
Torres, Harrys A., Anna S. Lok, María E. Suarez‐Almazor, et al.. (2020). Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study. Supportive Care in Cancer. 29(1). 97–105. 1 indexed citations
9.
Malek, Alexandre, Yago Nieto, Ariel D. Szvalb, et al.. (2019). Hepatitis B Virus-associated Liver Failure in a Patient With B-cell Non-Hodgkin Lymphoma After Anti-cancer Therapy Including Ibrutinib. Clinical Lymphoma Myeloma & Leukemia. 20(3). e124–e127. 10 indexed citations
10.
Economides, Minas P., Moran Amit, Parag Mahale, et al.. (2017). Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer. Cancer. 124(5). 960–965. 6 indexed citations
11.
Hosry, Jeff, Roberto N. Miranda, Felipe Samaniego, Minas P. Economides, & Harrys A. Torres. (2017). Clinicopathologic characteristics and outcomes of transformed diffuse large B‐cell lymphoma in hepatitis C virus‐infected patients. International Journal of Cancer. 142(5). 940–948. 13 indexed citations
12.
Torres, Harrys A., Terri Lynn Shigle, Nassim Hammoudi, et al.. (2017). The oncologic burden of hepatitis C virus infection: A clinical perspective. CA A Cancer Journal for Clinicians. 67(5). 411–431. 67 indexed citations
13.
Torres, Harrys A. & George B. McDonald. (2016). How I treat hepatitis C virus infection in patients with hematologic malignancies. Blood. 128(11). 1449–1457. 22 indexed citations
14.
Mahale, Parag, Erich M. Sturgis, David J. Tweardy, Ella Ariza‐Heredia, & Harrys A. Torres. (2016). Association Between Hepatitis C Virus and Head and Neck Cancers. JNCI Journal of the National Cancer Institute. 108(8). djw035–djw035. 50 indexed citations
15.
Hassan, Manal M., Reham Abdel‐Wahab, Ahmed O. Kaseb, et al.. (2015). Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology. 149(1). 119–129. 73 indexed citations
16.
Torres, Harrys A., Moises I. Nevah, Ben J. Barnett, et al.. (2012). Hepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: A retrospective multicenter study. Journal of Clinical Virology. 54(3). 218–222. 12 indexed citations
17.
Torres, Harrys A. & Marta Davila. (2012). Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nature Reviews Clinical Oncology. 9(3). 156–166. 123 indexed citations
18.
Torres, Harrys A. & Roy F. Chemaly. (2007). Viral infection or reactivation in patients during treatment with dasatinib: A call for screening?. Leukemia & lymphoma. 48(12). 2308–2309. 7 indexed citations
19.
Torres, Harrys A., Gerald P. Bodey, Jeffery Tarrand, & Dimitrios P. Kontoyiannis. (2003). Protothecosis in patients with cancer: case series and literature review. Clinical Microbiology and Infection. 9(8). 786–792. 59 indexed citations
20.
Torres, Harrys A., et al.. (2002). Open lung biopsy in bone marrow transplant recipients has a poor diagnostic yield for a specific diagnosis. Transplant Infectious Disease. 4(2). 80–84. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026